Dark

SGMO
Sangamo Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Apr 29, 2026 3:59:52 PM EDT

0.1300USD-33.930%(-0.0680)49,165,054

0.00Bid 0.00Ask 0.0000Spread

Pre-market

Apr 30, 2026 8:04:30 AM EDT

0.1271USD-4.291%(-0.0057)12,066

After-hours

Apr 29, 2026 4:56:30 PM EDT

0.1283USD-3.389%(-0.0045)262,607

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

54.97M

CEO

Alexander Macrae

Headquarters

Brisbane, California, USA

Industry

Biotechnology

Next Earnings

May 11, 2026 (11d)

AMGN BMRN SHPG GILD BIIB ALNY PDLI JNJ MRK DWDP XLV

SGMO Stats

Avg. Vol. 10 Day

8,020,063

Avg. Vol. 30 Day

7,887,561

Employees

209

Market Cap

54,974,162

Shares Out.

414,274,017

On/Off Exchange

37%/63%

6 Month Beta

1.83

1 Year Beta

1.70

2 Year Beta

1.51

3 Year Beta

1.54

52 Week Low

0.14

52 Week High

0.79

SMA50

0.33

SMA200

0.47

1 Week

-48.55%

1 Month

-56.82%

3 Month

-74.13%

6 Month

-77.12%

1 Year

-81.60%

2 Year

-74.59%

5 Year

-98.89%

Profile

for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.

SGMO Stock Summary

Sangamo Therapeutics, Inc. Common Stock (NASDAQ:SGMO) stock price today is $0.1300, and today's volume is 49,165,054. SGMO is down -33.930% today. The 30 day average volume is 7,887,561. SGMO market cap is 54.97M with 414,274,017 shares outstanding.